{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:29:30Z","timestamp":1776792570592,"version":"3.51.2"},"reference-count":19,"publisher":"Cold Spring Harbor Laboratory","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Mol Case Stud"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Genetic rearrangements involving <jats:italic>FLT3<\/jats:italic> are rare and only recently have been detected in myeloid\/lymphoid neoplasms associated with eosinophilia (MLN-eos) and chronic myeloproliferative disorders. Here we report two cases with <jats:italic>FLT3<\/jats:italic> fusions in patients demonstrating mixed features of myelodysplastic\/myeloproliferative neoplasms. In the first case, <jats:italic>FLT3<\/jats:italic> was fused with a new fusion partner <jats:italic>MYO18A<\/jats:italic> in a patient with marrow features most consistent with atypical chronic myeloid leukemia; the second case involving <jats:italic>ETV6<\/jats:italic>-<jats:italic>FLT3<\/jats:italic> fusion was observed in a case with bone marrow features most consistent with chronic myelomonocytic leukemia. Notably, we observed that samples from both patients demonstrated FLT3 inhibitor (quizartinib and sorafenib) sensitivity in ex vivo drug screening assay.<\/jats:p>","DOI":"10.1101\/mcs.a003079","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T19:49:20Z","timestamp":1545076160000},"page":"a003079","source":"Crossref","is-referenced-by-count":23,"title":["Two myeloid leukemia cases with rare <i>FLT3<\/i> fusions"],"prefix":"10.1101","volume":"4","author":[{"given":"Haijiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Paliga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evie","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Hien T.","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"246","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"2021112406072906000_4.6.a003079.1","doi-asserted-by":"crossref","unstructured":"Arsham MS , Shaffer LG . 2017. ISCN: the universal language of cytogenetics. In The AGT cytogenetics laboratory manual (ed. Arsham MS , ), pp. 359\u2013428. Wiley-Blackwell, New York.","DOI":"10.1002\/9781119061199.ch8"},{"key":"2021112406072906000_4.6.a003079.2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00277-013-1843-9","article-title":"Successful allogeneic stem cell transplantation with long-term remission of ETV6\/FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia","volume":"93","year":"2014","journal-title":"Ann Hematol"},{"key":"2021112406072906000_4.6.a003079.3","first-page":"10","article-title":"A novel TRIP11-FLT3 fusion in a patient with a myeloid\/lymphoid neoplasm with eosinophilia","volume":"216\u2013217","year":"2017","journal-title":"Cancer Genet"},{"key":"2021112406072906000_4.6.a003079.4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/leu.2014.168","article-title":"ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant","volume":"28","year":"2014","journal-title":"Leukemia"},{"key":"2021112406072906000_4.6.a003079.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.07.002"},{"key":"2021112406072906000_4.6.a003079.6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12308-014-0203-6","article-title":"ETV6\/FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia","volume":"7","year":"2014","journal-title":"J Hematop"},{"key":"2021112406072906000_4.6.a003079.7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-8-r72"},{"key":"2021112406072906000_4.6.a003079.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra044389"},{"key":"2021112406072906000_4.6.a003079.9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13039-017-0306-8","article-title":"Multiple MYO18A-PDGFRB fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)","volume":"10","year":"2017","journal-title":"Mol Cytogenet"},{"key":"2021112406072906000_4.6.a003079.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1169"},{"key":"2021112406072906000_4.6.a003079.11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/leu.2016.304","article-title":"A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?","volume":"31","year":"2017","journal-title":"Leukemia"},{"key":"2021112406072906000_4.6.a003079.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1906"},{"key":"2021112406072906000_4.6.a003079.13","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.058073"},{"key":"2021112406072906000_4.6.a003079.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2012.02.006"},{"key":"2021112406072906000_4.6.a003079.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404266"},{"key":"2021112406072906000_4.6.a003079.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403712"},{"key":"2021112406072906000_4.6.a003079.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-343426"},{"key":"2021112406072906000_4.6.a003079.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-248302"},{"key":"2021112406072906000_4.6.a003079.19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.126"}],"container-title":["Molecular Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/mcs.a003079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T14:13:57Z","timestamp":1637763237000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularcasestudies.cshlp.org\/lookup\/doi\/10.1101\/mcs.a003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,17]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1101\/mcs.a003079"],"URL":"https:\/\/doi.org\/10.1101\/mcs.a003079","relation":{},"ISSN":["2373-2865","2373-2873"],"issn-type":[{"value":"2373-2865","type":"print"},{"value":"2373-2873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}